Aptose Biosciences Surges Ahead with Q1 Earnings
Aptose Biosciences Surges Ahead with Q1 Earnings
Source: iQoncept / Shutterstock Aptose Biosciences (NASDAQ:APTO) recently unveiled its performance for the initial quarter of 2024. Aptose Biosciences surpassed expectations by reporting earnings per share of -73 cents, slightly better than the projected -74 cents. Despite this positive development, the company did not disclose any revenue figures for the period. InvestorPlace Earnings, fueled by ...












